(ARWR) Arrowhead Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Arrowhead Pharmaceuticals | (ARWR) share price targets
Complete technical analysis of Arrowhead Pharmaceuticals (ARWR) by charts plus indicators, forecast predictions and share price targets for Arrowhead Pharmaceuticals (ARWR)
Arrowhead Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Arrowhead Pharmaceuticals is 1126660
| Date | Daily Closing Price | Open | High | Low | Volume |
| 26 Tue Nov 2024 | 21.05 | 22.95 | 24.23 | 20.85 | 7.147 times |
| 25 Mon Nov 2024 | 18.79 | 18.99 | 19.84 | 18.73 | 1.337 times |
| 22 Fri Nov 2024 | 18.54 | 18.30 | 18.87 | 18.13 | 0.92 times |
| 21 Thu Nov 2024 | 18.28 | 18.75 | 18.83 | 18.21 | 0.674 times |
| 20 Wed Nov 2024 | 18.71 | 18.56 | 18.75 | 18.03 | 0.703 times |
| 19 Tue Nov 2024 | 18.60 | 18.98 | 18.99 | 18.45 | 0.886 times |
| 18 Mon Nov 2024 | 19.02 | 18.81 | 19.10 | 18.18 | 1.15 times |
| 15 Fri Nov 2024 | 18.57 | 21.12 | 21.25 | 18.54 | 1.694 times |
| 14 Thu Nov 2024 | 21.41 | 21.64 | 22.00 | 21.17 | 1.032 times |
| 13 Wed Nov 2024 | 21.63 | 21.70 | 22.03 | 21.38 | 0.854 times |
Stock of Arrowhead Pharmaceuticals (ARWR) has showed a significant upmove. This could be a good time to enter in this stock!
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 21.4 as stoploss in an intra day sell trade for a target of 20.09. However, stock will show a bullish move above 21.4.
Share price targets for Arrowhead Pharmaceuticals (ARWR)
| Target Type | Value |
| Downside Target | 17.05 |
| Downside Target | 18.03 |
| Downside Target | 18.54 |
| Downside Target | 20.87 |
| Upside Target | 21.44 |
| Upside Target | 21.92 |
| Upside Target | 22.51 |
| Upside Target | 24.23 |
| Upside Target | 24.57 |
| Upside Target | 24.77 |
| Upside Target | 28.72 |
| Upside Target | 30.41 |
Intraday share price targets for Arrowhead Pharmaceuticals (ARWR)
| Target Type | Value |
| Downside Intraday Target | 18.44 |
| Downside Intraday Target | 15.84 |
| Upside Intraday Target | 23.94 |
| Upside Intraday Target | 26.84 |
| Upside Intraday Target | 21.34 |
Weekly technical analysis of Arrowhead Pharmaceuticals (ARWR)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 26 Tue Nov 2024 | 21.05 | 18.99 | 24.23 | 18.73 | 1.958 times |
| 22 Fri Nov 2024 | 18.54 | 18.81 | 19.10 | 18.03 | 0.795 times |
| 15 Fri Nov 2024 | 18.57 | 22.13 | 22.51 | 18.54 | 0.991 times |
| 08 Fri Nov 2024 | 21.89 | 19.54 | 21.92 | 19.22 | 1.578 times |
| 01 Fri Nov 2024 | 19.49 | 20.47 | 20.87 | 19.20 | 1.065 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Arrowhead Pharmaceuticals (ARWR)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 26 Tue Nov 2024 | 21.05 | 19.55 | 24.23 | 18.03 | 1.255 times |
| 31 Thu Oct 2024 | 19.23 | 19.20 | 21.44 | 17.05 | 0.941 times |
| 30 Mon Sep 2024 | 19.37 | 24.02 | 24.77 | 19.07 | 1.039 times |
| 30 Fri Aug 2024 | 23.83 | 28.46 | 28.72 | 22.11 | 1.161 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arrowhead Pharmaceuticals (ARWR)
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arrowhead Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arrowhead Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.03 and Arrowhead Pharmaceuticals (ARWR) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arrowhead Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arrowhead Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.03 and Arrowhead Pharmaceuticals (ARWR) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.